Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease

Ruben Yannick GabriĆ«ls  1     Arno R. Bourgonje  1     Julius Z. H. von Martels  1     Guido Trentadue  1     Tjasso Blokzijl  1     Hendrik M. van Dullemen  2     Eleonora A. M. Festen     Marijn C. Visschedijk     Rinse K. Weersma     Gursah Kats-Ugurlu     Klaas Nico Faber     Gerard Dijkstra    
1 University Medical Center Groningen,Groningen,Netherlands
2 University Medical Center Groningen,Groni

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing